A detailed history of Jpmorgan Chase & CO transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28,358 shares of PROK stock, worth $43,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,358
Previous 20,812 36.26%
Holding current value
$43,954
Previous $34,000 102.94%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.44 - $4.2 $10,866 - $31,693
7,546 Added 36.26%
28,358 $69,000
Q1 2024

May 10, 2024

SELL
$1.2 - $1.76 $11,102 - $16,283
-9,252 Reduced 30.77%
20,812 $34,000
Q4 2023

Feb 12, 2024

BUY
$1.21 - $4.76 $160 - $633
133 Added 0.44%
30,064 $53,000
Q3 2023

Nov 14, 2023

SELL
$4.32 - $13.08 $78,088 - $236,434
-18,076 Reduced 37.65%
29,931 $137,000
Q2 2023

Aug 11, 2023

BUY
$9.0 - $13.0 $393,525 - $568,425
43,725 Added 1021.13%
48,007 $537,000
Q1 2023

May 11, 2023

BUY
$6.1 - $13.78 $5,581 - $12,608
915 Added 27.18%
4,282 $48,000
Q4 2022

Feb 13, 2023

BUY
$5.47 - $11.38 $18,417 - $38,316
3,367 New
3,367 $23,000

Others Institutions Holding PROK

About PROKIDNEY CORP ORD SHS CL A(CY


  • Ticker PROK
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,540,200
  • Market Cap $95.4M
More about PROK
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.